ZEPBOUND

tirzepatide · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for ZEPBOUND, covering 2023-11-08 to 2026-08-26. Get the full timeline:

Most recent: FDA Approved: ZEPBOUND — Supplemental Application (Eli Lilly and Company)